Track: Interface

« Back

Print this page

	Personalized Program The Personalized Program enables you to compile an individual program with events and contributions of your interest. Therefore, it can be used very well to plan your actual congress visit at an early point of time. Please log in to use the Personalized Program.	» Login » Identification » Help

	Sunday, 28. June 2009	next day »

No.	S-05 - Symposium
Time:	08.00-09.30
Room:	Room 241
Topic:	Neuroimaging
Track:	3 Interface
Session title:	Near-infrared spectroscopy (NIRS) in psychiatry: Current status and future prospect
	Masato Fukuda, Japan	Chair
	Andreas J. Fallgatter, Germany	Co-Chair

001	Bilateral frontal activation during a phonological working memory task in schizophrenic patients
	Sohee Park, USA	Speaker
002	Near-infrared spectroscopy in mood disorders
	Masato Fukuda, Japan	Speaker
003	NIRS in Attention-Deficit / Hyperactivity Disorder (ADHD)
	Andreas J. Fallgatter, Germany	Speaker
004	Clinical NIRS application to psychiatric diagnosis and evaluation
	Ryu Takizawa, Japan	Speaker

No.	S-13 - Symposium
Time:	14.00-15.30
Room:	Blue Amphitheatre
Topic:	Brain Function
Track:	3 Interface
Session title:	Translational neuroscience: Do we learn anything for psychiatric practice?
	Dieter F. Braus, Germany	Chair
	Gabriele Sachs, Austria	Co-Chair

001	Neuroimaging in psychiatry
	Dieter F. Braus, Germany	Speaker
002	Sensorimotor gating and the tale of the prediction of antipsychotic effects
	Boris Quednow, Switzerland	Speaker
003	Biomarkers of affective disorders
	Lukas Pezawas, Austria	Speaker
004	Neurobiology of psychotherapy
	Gabriele Sachs, Austria	Speaker

No.	S-17 - Symposium
Time:	14.00-15.30
Room:	Room 241
Topic:	Anxiety
Track:	3 Interface
Session title:	Translational neuroscience may inform treatment development for posttraumatic stress disorder
	Leo Sher, USA	Chair
	Alexander Neumeister, USA	Co-Chair

001	Early postnatal stress: Impact on neural circuits and relevance to psychophysiology
	Machiko Matsumoto, Japan	Speaker
002	Long term alterations in brain and neurobiology in PTSD
	Eric Vermetten, Netherlands	Speaker
003	Mechanisms of resilience: Lessons from PET imaging
	Alexander Neumeister, USA	Speaker
004	Neurobiology of suicidal behavior in PTSD and implications for suicide prevention
	Leo Sher, USA	Speaker

No.	S-18 - Symposium
Time:	14.00-15.30
Room:	Room 251
Topic:	Genetics
Track:	3 Interface
Session title:	Neurosciences of suicidal behaviour: New targets for prevention?
	Philippe Courtet, France	Chair
	Alec Roy, France	Co-Chair

001	What genes tell us - ethical perspectives
	Alain Malafosse, Switzerland	Speaker
002	Will emotional and cognitive endophenotypes provide new therapeutic targets?
	Philippe Courtet, France	Speaker
003	Predictive value of genetic findings: New analytical methods
	Enrique Baca Garcia, Spain	Speaker
004	Suicide risk in prisoners: Genes environment interactions
	Marco Sarchiapone, Italy	Speaker

No.	S-20 - Symposium
Time:	16.00-17.30
Room:	Blue Amphitheatre
Topic:	Brain Function
Track:	3 Interface
Session title:	Deep brain stimulation in repetitive behaviors
	Luc Mallet, France	Chair
	Paul Cosyns, Belgium	Co-Chair

001	Ventral capsule/ventral striatum stimulation in obsessive-compulsive disorder
	Benjamin Greenberg, USA	Speaker
002	Anatomical correlates of deep brain stimulation efficacy in obsessive compulsive disorder
	Leos Gabriels, Belgium	Speaker
003	Deep brain stimulation of the nucleus accumbens for therapy-refractory obsessive-compulsive disorder
	Damiaan Denys, Netherlands	Speaker
004	Effect of stimulation of limbic relays in basal ganglia on tics and compulsions
	Marie-Laure Welter, France	Speaker

No.	S-23 - Symposium
Time:	16.00-17.30
Room:	Room 252B
Topic:	Addictive Disorders
Track:	3 Interface
Session title:	Are first experiences with alcohol predicting later risk of alcohol-dependence? Clinical and biological approaches
	Pierre-Marie Llorca, France	Chair
	Wei J. Chenb, Taiwan	Co-Chair

001	Alcohol consumption and dependence: A study of medical students
	Sami Richa, Lebanon	Speaker
002	Early alcohol experiences and adolescent mental health: A population-based study in Taiwan
	Wei J. Chenb, Taiwan	Speaker
003	Alcohol initiation experiences and family history of alcoholism as predictors of problem-drinking trajectories
	Warner La, USA	Speaker

No.	S-24 - Symposium
Time:	16.00-17.30
Room:	Room 241
Topic:	Childhood Adolescent Disorder
Track:	3 Interface
Session title:	The possible role of Oxytocin as a key molecule in the new treatment and in the pathogenesis of autism-spectrum disorder
	Nobumasa Kato, Japan	Chair
	Michael Lombardo, United Kingdom	Co-Chair

001	Introduction
	Nobumasa Kato, Japan	Speaker
002	Possible animal model of autism
	Haruhiro Higashida, Japan	Speaker
003	Neuroimage of autism: Neural basis of oxytocin
	Hidenori Yamasue, Japan	Speaker
004	Neural correlates of social cognition
	Michael Lombardo, United Kingdom	Speaker

No.	S-25 - Symposium
Time:	16.00-17.30
Room:	Room 251
Topic:	Anxiety
Track:	3 Interface
Session title:	Peripheral and central mechanisms involved in post-traumatic stress disorder and its treatment
	Stephanie Khalfa, France	Chair
	Tanja Michael, Switzerland	Co-Chair

001	Translational research in the neuroscience of fear extinction: Implications to PTSD and other anxiety disorders
	Mohammed R. Milad, USA	Speaker
002	Variability of symptoms in daily life of patients with PTSD
	Tanja Michael, Switzerland	Speaker
003	Update on biopsychological correlates and predispositions of PTSD and its successful CBT treatment
	Anke Karl, United Kingdom	Speaker
004	Fear conditioning/extinction in PTSD before and after treatment
	Stephanie Khalfa, France	Speaker

« previous day	Monday, 29. June 2009	next day »

No.	S-32 - Symposium
Time:	11.00-12.30
Room:	Salle Maillot
Topic:	Neurodegenerative Disorders
Track:	3 Interface
Session title:	Depression and dementia: Stress hormones and neuroprotection
	Edith Holsboer-Trachsler, Switzerland	Chair
	Luc Staner, France	Co-Chair

001	Role of neurosteroids and oxidative stress in neurodegeneration
	Anne Eckert, Switzerland	Speaker
002	Neuropeptide regulation and sleep in aging and depression
	Axel Steiger, Germany	Speaker
003	Can hormones provide natural neuroprotectivity: Melatonin and estrogen in neurodegeneration?
	Egemen Savaskan, Switzerland	Speaker
004	Antidepressants, age related sleep alterations and depression
	Luc Staner, France	Speaker

No.	S-35 - Symposium
Time:	11.00-12.30
Room:	Room 241
Topic:	Addictive Disorders
Track:	3 Interface
Session title:	Behavioral addictions: Neurobiology and treatment
	David A. Gorelick, USA	Chair
	Aviv Weinstein, Israel	Co-Chair

001	The neuropsychopharmacology of pathological gambling
	Marc Potenza, USA	Speaker
002	Compulsive buying
	Michel Lejoyeux, France	Speaker
003	Sexual addiction and paraphilias
	Florence Thibaut, France	Speaker
004	Dopamine release during computer game playing
	Aviv Weinstein, Israel	Speaker

No.	S-36 - Symposium
Time:	11.00-12.30
Room:	Room 251
Topic:	Psychotic Disorders
Track:	3 Interface
Session title:	Psychophysiological endophenotypic makers in prodromal and first-episode schizophrenia patients
	Birte Glenthoj, Denmark	Chair
	Raquel Gur, USA	Co-Chair

001	Endophenotype candidacy of key psychophysiological disturbances in schizophrenia
	Raquel Gur, USA	Speaker
002	Deficits in prepulse Inhibition in the prodrome of schizophrenia
	Boris Quednow, Switzerland	Speaker
003	Effects of a six month antipsychotic treatment on sensory(motor) gating and its neural generators: A longitudinal study of antipsychotic-naive first-episode schizophrenic patients
	Bob Oranje, Denmark	Speaker
004	Vulnerability markers in the prodrome in early psychosis: Predicting outcome and understanding the mechanism
	Kristin Cadenhead, USA	Speaker

No.	S-38 - Symposium
Time:	16.00-17.30
Room:	Salle Maillot
Topic:	Neuroimaging
Track:	3 Interface
Session title:	Brain imaging in drug development: Traditional nosological versus endophenotype-directed approaches
	Gerhard Gründer, Germany	Chair
	Franz Vollenweider, Switzerland	Co-Chair

001	MRI-based endophenotyping as outset for drug targeting
	Franz Vollenweider, Switzerland	Speaker
002	From nosological to endophenotype-directed drug targeting: The role of PET
	Gerhard Gründer, Germany	Speaker
003	The role of PET in early risk discharge in CNS drug development
	Marc Laruelle, United Kingdom	Speaker
004	Enabling personalized medicine through novel imaging techniques in drug development
	Johannes Tauscher, USA	Speaker

No.	S-40 - Symposium
Time:	16.00-17.30
Room:	Room 252B
Topic:	Anxiety
Track:	3 Interface
Session title:	New insight into panic disorder
	Eduard Maron, Estonia	Chair
	David Nutt, United Kingdom	Co-Chair

001	Perspectives in research and treatment of panic disorder
	David Nutt, United Kingdom	Speaker
002	Challenge tests
	Jakov Shlik, Canada	Speaker
003	Genetics of panic disorder: New evidences
	Francis McMahon, USA	Speaker
004	Neuroimaging of panic disorder
	Eduard Maron, Estonia	Speaker

« previous day	Tuesday, 30. June 2009	next day »

No.	S-43 - Symposium
Time:	08.00-09.30
Room:	Blue Amphitheatre
Topic:	Brain Function
Track:	3 Interface
Session title:	Immune activation and tryptophan metabolism in major psychiatric disorders
	Markus J. Schwarz, Germany	Chair
	Gilles Guillemin, Australia	Co-Chair

001	Tryptophan metabolism by astrocytes and microglia in neurodegenerative diseases
	Gilles Guillemin, Australia	Speaker
002	The outcome of postmortem studies of schizophrenia and bipolar disorder: Genes of relevance to tryptophan metabolism
	Christine L. Miller, USA	Speaker
003	Immune and tryptophan catabolic markers in blood and cerebrospinal fluid of patients with major depression and schizophrenia
	Aye-Mu Myint, Germany	Speaker
004	Immunomodulating therapy in major depression and schizophrenia
	Norbert Müller, Germany	Speaker

No.	S-44 - Symposium
Time:	08.00-09.30
Room:	Salle Maillot
Topic:	Affective Disorders (Bipolar)
Track:	3 Interface
Session title:	60 years of lithium in neuropsychiatry - recent discoveries in basic and clinical research
	Michael Bauer, Germany	Chair
	Janusz Rybakowski, Poland	Co-Chair

001	Response to long-term lithium treatment and its use as an endophenotype for bipolar disorder
	Martin Alda, Canada	Speaker
002	Neuroprotective properties of lithium
	Robert Belmaker, Israel	Speaker
003	Genome-wide findings from the Consortium on Lithium Genetics (ConLiGen)
	Thomas G. Schulze, USA	Speaker
004	Lithium at work: The neurobiologist's perspective -from animal models to the development of novel therapeutics
	Husseini Manji, USA	Speaker

No.	S-45 - Symposium
Time:	08.00-09.30
Room:	Room 352AB
Topic:	Psychopharmacology
Track:	3 Interface
Session title:	Are biological measures useful in predicting antipsychotic treatment response in schizophrenia?
	Monte Buchsbaum, USA	Chair
	Herbert Meltzer, USA	Co-Chair

001	Prediction of antipsychotic response with diffusion tensor imaging
	M. Mehmet Haznedar, USA	Speaker
002	Pharmacogenetic prediction of antipsychotic response
	Maria Arranz, United Kingdom	Speaker
003	Predicting best treatment response in schizophrenia with striatal function
	Erin Hazlett, USA	Speaker
004	Loudness dependence of auditory evoked potentials as predictor of therapeutical response to psychotropic medication
	Georg Juckel, Germany	Speaker

No.	S-47 - Symposium
Time:	08.00-09.30
Room:	Room 241
Topic:	Genetics
Track:	3 Interface
Session title:	Biological markers and clinical features in depression: A difficult puzzle
	Eduardo Rubio Dominguez, Argentina	Chair
	Florence Thibaut, France	Co-Chair

001	The relevant relationship between genetic and clinical presentation
	Raquel Teresa Zamora-Cabral, Uruguay	Speaker
002	Neuropsycological endophenotypes in bipolar disorder
	Carlos Lopez Jaramillo, Colombia	Speaker
003	International studies on SERT and subtypes of depression - an update
	Andrea Lopez Mato, Argentina	Speaker
004	Correlation between the Serotonin transporter gene in depressive patients and suicide victims
	Patricia Chieri, Argentina	Speaker

No.	S-52 - Symposium
Time:	11.00-12.30
Room:	Room 241
Topic:	Neurodegenerative Disorders
Track:	3 Interface
Session title:	Clinical and biological aspect of apathy in neuropsychiatry
	Philippe Robert, France	Chair
	Albert Leentjens, Netherlands	Co-Chair

001	The concept of apathy in Alzheimer's disease
	Albert Leentjens, Netherlands	Speaker
002	Apathy in other neurodegenerative diseases
	Kathy Dujardin, France	Speaker
003	Ambulatory actigraphy for the evaluation of apathy in Alzheimer's disease
	Renaud David, France	Speaker
004	Discussion
	Philippe Robert, France	Speaker

No.	S-56 - Symposium
Time:	16.00-17.30
Room:	Room 352AB
Topic:	Psychopharmacology
Track:	3 Interface
Session title:	Recent developments in affective disorders during pregnancy and lactation
	Angelika Wieck, United Kingdom	Chair
	Carmine Pariante, United Kingdom	Co-Chair

001	Recent developments in antenatal depression
	Carmine Pariante, United Kingdom	Speaker
002	New data on the reproductive safety of antidepressant drugs
	Margareta Reis, Sweden	Speaker
003	New insights into bipolar disorder in childbearing women
	Ian Jones, United Kingdom	Speaker
004	The safety of mood stabilizing medication in pregnancy and lactation
	Salvatore Gentile, Italy	Speaker

No.	S-59 - Symposium
Time:	16.00-17.30
Room:	Room 251
Topic:	Brain Function
Track:	3 Interface
Session title:	New strategies and tools in the field of transcranial magnetic stimulation (TMS)
	Yechiel Levkovitz, Israel	Chair
	Frank Padberg, Germany	Co-Chair

001	Deep transcranial magnetic stimulation in major depression: Feasibility and safety study
	Yechiel Levkovitz, Israel	Speaker
002	New protocols of non-invasive brain stimulation: Enhancing the after-effect
	Frank Padberg, Germany	Speaker
003	Gamma synchrony, GABAB and rTMS cognitive enhancing strategies in schizophrenia
	Z. Jeff Daskalakis, Canada	Speaker
004	Physiological optimization of TMS pulse shape and parameters for therapeutic applications: Controllable pulse shape TMS (cTMS) and magnetic seizure therapy (MST)
	Sarah H. Lisanby, USA	Speaker

« previous day	Wednesday, 1. July 2009	next day »

No.	S-65 - Symposium
Time:	08.00-09.30
Room:	Room 251
Topic:	Psychotic Disorders
Track:	3 Interface
Session title:	Functional psychopathology: Linking neurobiology with psychopathology
	Wolfgang Gaebel, Germany	Chair
	Veronica Larach-Walters, Chile	Co-Chair

001	Philosophical foundations of the relation between neurobiology and psychopathology
	Michael Musalek, Austria	Speaker
002	An introduction to functional psychopathology
	Wolfgang Gaebel, Germany	Speaker
003	Modules of the brain: Linking brain function to psychopathology
	Jürgen Zielasek, Germany	Speaker
004	Treatment of social cognition impairments in schizophrenia regarding facial affect recognition
	Veronica Larach-Walters, Chile	Speaker

« previous day	Thursday, 2. July 2009

No.	S-77 - Symposium
Time:	08.00-09.30
Room:	Salle Maillot
Topic:	Other
Track:	3 Interface
Session title:	Strengths and weaknesses of evidence-based medicine (EBM) in general and its particular role in psychiatry
	Michael Davidson, Israel	Chair

No.	S-83 - Symposium
Time:	11.00-12.30
Room:	Room 252B
Topic:	Psychopharmacology
Track:	3 Interface
Session title:	Newer antipsychotic drugs: From neuroplasticity to neurotherapy
	Frank Tarazi, USA	Chair
	Marco Riva, Italy	Co-Chair

001	Neuroplasticity and signaling in the action of atypical antipsychotic drugs: Implications for functional recovery
	Marco Riva, Italy	Speaker
002	Receptor neuroplasticity of newer antipsychotic drugs
	Frank Tarazi, USA	Speaker
003	Serotonergic properties of antipsychotic drugs: Relevance to neuroplasticity
	Mohammed Shahid, United Kingdom	Speaker
004	Neuroplasticity as a target for innovative treatments. Effect of Clozapine in two animal models of schizophrenia.
	William T. O'Connor, Ireland	Speaker

No.	S-84 - Symposium
Time:	11.00-12.30
Room:	Room 241
Topic:	Childhood Adolescent Disorder
Track:	3 Interface
Session title:	Acute neuropsychiatric states in autism
	David Cohen, France	Chair
	Dirk Dhossche, USA	Co-Chair

001	Acute behavioral states in adolescent with autism hospitalized in a psychiatric intensive care unit
	David Cohen, France	Speaker
002	Catatonia in autism: Implications across the life span
	Dirk Dhossche, USA	Speaker
003	Self-injurious behavior in autism: Etiology, assessment and treatment
	Lea Elisabeth Wachtel, USA	Speaker
004	The role of epilepsy in children and adolescents with autism spectrum disorders
	Roberto Canitano, Italy	Speaker

No.	S-87 - Symposium
Time:	14.00-15.30
Room:	Salle Maillot
Topic:	Affective Disorders (Bipolar)
Track:	3 Interface
Session title:	Clinical and biological correlates of outcome prediction in major psychoses
	Carlo Altamura, Italy	Chair
	Trevor Young, Canada	Co-Chair

001	Bipolar disorder
	Trevor Young, Canada	Speaker
002	Neuromorphology and outcome prediction
	Philip McGuire, France	Speaker
003	Psychoimmunology and drug response
	Norbert Müller, Germany	Speaker
004	Duration of untreated psychosis: is it a criterion for outcome prediction?
	Carlo Altamura, Italy	Speaker

« Back

---